US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Azitra Inc

0.2701

-0.0104-3.71%

Post-market: 0.2700-0.0001-0.04%19:52 EDT

Volume:464.77K

Turnover:126.94K

Market Cap:4.45M

PE:-0.11

High:0.2837

Open:0.2700

Low:0.2660

Close:0.2805

Loading ...

Overview Company News Filings

BRIEF-Azitra, Inc. Announces Q1 2025 Results And Provides Business Updates

Anitra Q1 EPS $(0.23) Up From $(4.32) YoY

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates

THOMSON REUTERS

Press Release: Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025

Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership With Alumni Capital to Fund Clinical Pipeline

THOMSON REUTERS

Press Release: Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline

AZTR: Netherton Topline Expected by Year-End

Zacks Small Cap Research

Maxim Group Reaffirms Their Buy Rating on Azitra Inc (AZTR)

Azitra FY24 EPS $(2.37) Vs $(54.98) YoY; Revenue $7.5K Vs $686K YoY

Press Release: Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates

Azitra Prices $930,000 Registered Direct Offering

MT Newswires Live

Azitra sees 3.34M shares at 27.85c in registered direct offering

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock

THOMSON REUTERS

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock

US Stocks Mixed; PepsiCo Posts Downbeat Sales

Azitra, Inc. to Present at the BIO CEO & Investor Conference

Azitra, Inc. to Present at The Microcap Conference

Dow Jumps 600 Points; US Inflation Increases To 2.9% In December

Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AZTR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AZTR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZTR\",,,,,undefined,":{"symbol":"AZTR","market":"US","secType":"STK","nameCN":"Azitra Inc","latestPrice":0.2701,"timestamp":1747425600000,"preClose":0.2805,"halted":0,"volume":464774,"hourTrading":{"tag":"盘后","latestPrice":0.27,"preClose":0.2701,"latestTime":"19:52 EDT","volume":22548,"amount":6235.8511,"timestamp":1747439566341},"delay":0,"floatShares":14858699,"shares":16476354,"eps":-2.369542,"marketStatus":"Market Closed","change":-0.0104,"latestTime":"05-16 16:00:00 EDT","open":0.27,"high":0.283659,"low":0.266,"amount":126940.71553222,"amplitude":0.062955,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.369542,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747641600000},"marketStatusCode":7,"adr":0,"listingDate":1684382400000,"exchange":"AMEX","adjPreClose":0.2805,"preHourTrading":{"tag":"盘前","latestPrice":0.2857,"preClose":0.2805,"latestTime":"09:15 EDT","volume":13284,"amount":3622.16767464,"timestamp":1747401341829},"postHourTrading":{"tag":"盘后","latestPrice":0.27,"preClose":0.2701,"latestTime":"19:52 EDT","volume":22548,"amount":6235.8511,"timestamp":1747439566341},"volumeRatio":0.6764686363391029},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZTR\",,,,,undefined,":{"symbol":"AZTR","floatShares":14858699,"roa":"-116.11%","roe":"-208.50%","lyrEps":-2.369542,"volumeRatio":0.6764686363391029,"shares":16476354,"dividePrice":0,"high":0.283659,"amplitude":0.062955,"preClose":0.2805,"low":0.266,"week52Low":0.2325,"pbRate":"1.01","psRate":"593.37","week52High":12,"institutionHeld":0,"latestPrice":0.2701,"eps":-2.369542,"divideRate":0,"volume":464774,"delay":0,"ttmEps":-2.369542,"open":0.27,"prevYearClose":0.4255,"prevWeekClose":0.295,"prevMonthClose":0.3232,"prevQuarterClose":0.303,"fiveDayClose":0.295,"twentyDayClose":0.285,"sixtyDayClose":0.409},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZTR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535354140","title":"BRIEF-Azitra, Inc. Announces Q1 2025 Results And Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2535354140","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535354140?lang=en_us&edition=fundamental","pubTime":"2025-05-14 06:15","pubTimestamp":1747174537,"startTime":"0","endTime":"0","summary":"BRIEF-Azitra, Inc. Announces Q1 2025 Results And Provides Business UpdatesMay 13 (Reuters) - Azitra Inc AZTR.A:AZITRA, INC. ANNOUNCES Q1 2025 RESULTS AND PROVIDES BUSINESS UPDATESSource text: ID:nPn5RMYJTaFurther company coverage: AZTR.A ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA7KJ2XH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"gpt_icon":0},{"id":"2535003882","title":"Anitra Q1 EPS $(0.23) Up From $(4.32) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2535003882","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535003882?lang=en_us&edition=fundamental","pubTime":"2025-05-14 05:08","pubTimestamp":1747170526,"startTime":"0","endTime":"0","summary":"Anitra (AMEX:AZTR) reported quarterly losses of $(0.23) per share. This is a 94.68 percent increase over losses of $(4.32) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45393030/anitra-q1-eps-0-23-up-from-4-32-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR"],"gpt_icon":0},{"id":"2535080059","title":"Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2535080059","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535080059?lang=en_us&edition=fundamental","pubTime":"2025-05-14 05:06","pubTimestamp":1747170364,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA7KJ2XH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AZTR"],"gpt_icon":0},{"id":"2535038351","title":"Press Release: Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2535038351","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535038351?lang=en_us&edition=fundamental","pubTime":"2025-05-14 05:06","pubTimestamp":1747170360,"startTime":"0","endTime":"0","summary":"BRANFORD, Conn., May 13, 2025 /PRNewswire/ -- Azitra, Inc. , a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the quarter ended March 31, 2025, and provided a business update.-- Announced acceptance of poster detailing the Phase 1/2 clinical trial of. the ATR-04 program in EGFR inhibitor -associated rash at the. 2025 American Society of Clinical Oncology  Annual Meeting. -- Entered into Purchase Agreement for up to $20 Million in Partnership with. institutional investor Alumni Capital LP, to fund clinical pipeline. \"The start of 2025 has been a vital period for Azitra as we build towards key milestones expected by mid-year for our first-in-class, precision, live biotherapeutic candidates designed for major undertreated dermatological diseases,\" said Francisco Salva, CEO of Azitra. \"For ATR-12, our lead program targeting the rare, chronic and devastating Netherton syndrome, we expect to ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"gpt_icon":0},{"id":"2530138857","title":"Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2530138857","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530138857?lang=en_us&edition=fundamental","pubTime":"2025-04-25 20:33","pubTimestamp":1745584380,"startTime":"0","endTime":"0","summary":"Azitra is developing ATR04-484 for the treatment ofEGFR inhibitor-associated rash with plans to dose first patient in Phase 1/2 trial in the first half of 2025. BRANFORD,Conn., April 25, 2025 /PRNewswire/ -- Azitra, Inc. , a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that an abstract detailing the Phase 1/2 clinical trial of ATR04-484 in EGFR inhibitor -associated rash has been accepted for presentation at the 2025 American Society of Clinical Oncology  Annual Meeting being held May 30-June 3, 2025 in Chicago.Azitra, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology. The Company's lead program, ATR-12, uses an engineered strain of S. epidermidis designed to treat Netherton syndrome, a rare, chronic skin disease with no approved treatment options. Netherton syndrome may be fatal in infancy with those living beyond a year having profoun","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/azitra-inc-present-atr-04-123300411.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/azitra-inc-present-atr-04-123300411.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4126","ATR","BK4139","AZTR"],"gpt_icon":0},{"id":"2530606209","title":"Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership With Alumni Capital to Fund Clinical Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2530606209","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530606209?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:05","pubTimestamp":1745525115,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nTUAC40BTM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AZTR","BK4139"],"gpt_icon":0},{"id":"2530960148","title":"Press Release: Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2530960148","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530960148?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:05","pubTimestamp":1745525100,"startTime":"0","endTime":"0","summary":"Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline. BRANFORD, Conn., April 24, 2025 /PRNewswire/ -- Azitra, Inc. , a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that it has entered into a share purchase agreement  with Alumni Capital LP , an institutional investor. Azitra anticipates that this partnership will provide Azitra with a flexible source of funding, enabling the Company to progress its pipeline of live biotherapeutic precision products delivered topically to treat rare and severe dermatologic conditions.Azitra, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology. The Company's lead program, ATR-12, uses an engineered strain of S. epidermidis designed to treat Netherton syndrome, a rare, chronic skin disease with no approved treatment options. Netherton sy","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4139"],"gpt_icon":0},{"id":"2516563271","title":"AZTR: Netherton Topline Expected by Year-End","url":"https://stock-news.laohu8.com/highlight/detail?id=2516563271","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516563271?lang=en_us&edition=fundamental","pubTime":"2025-03-03 17:39","pubTimestamp":1740994740,"startTime":"0","endTime":"0","summary":"Azitra, Inc.  reported 2024 results in a February press release highlighting several achievements and company goals. The Phase Ib clinical trial for ATR-12 in Netherton syndrome has started and is expected to produce initial safety data in the next few months. Activity is robust for the ATR-04 program in EGFRi skin rash with Fast Track status and FDA clinical study clearance granted for a Phase I/II study. The ATR-04 trial is slated to begin this spring. Other activity includes capital raises to support the clinical trial work and new patents granted and allowed. Azitra management has been busy participating in several investor and industry conferences including the Microcap Conference, Biotech Showcase, BIO-CEO and the European Academy of Dermatology meetings.Following the end of the reporting period, Azitra raised an additional $2.2 mil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aztr-netherton-topline-expected-end-093900351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","AZTR"],"gpt_icon":0},{"id":"2514661848","title":"Maxim Group Reaffirms Their Buy Rating on Azitra Inc (AZTR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514661848","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514661848?lang=en_us&edition=fundamental","pubTime":"2025-02-27 02:06","pubTimestamp":1740593160,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Azitra Inc (AZTR – Research Report). The company’s share...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-reaffirms-their-buy-rating-on-azitra-inc-aztr?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-reaffirms-their-buy-rating-on-azitra-inc-aztr?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AZTR"],"gpt_icon":0},{"id":"2513729282","title":"Azitra FY24 EPS $(2.37) Vs $(54.98) YoY; Revenue $7.5K Vs $686K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2513729282","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513729282?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:37","pubTimestamp":1740404255,"startTime":"0","endTime":"0","summary":"Azitra FY24 EPS $(2.37) Vs $(54.98) YoY; Revenue $7.5K Vs $686K YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/02/43911070/azitra-fy24-eps-2-37-vs-54-98-yoy-revenue-7-5k-vs-686k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Azitra FY24 EPS $(2.37) Vs $(54.98) YoY; Revenue $7.5K Vs $686K YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR"],"gpt_icon":0},{"id":"2513272912","title":"Press Release: Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2513272912","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513272912?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:30","pubTimestamp":1740403800,"startTime":"0","endTime":"0","summary":"BRANFORD, Conn., Feb. 20, 2025 /PRNewswire/ -- Azitra, Inc. , a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the full year ended December 31, 2024, and provided a business update.-- Initiated a Phase 1b clinical trial investigating ATR-12 in adult. Netherton syndrome patients; Initial safety data from first set of. -- Received clearance from the U.S. Food and Drug Administration  for a. -- FDA granted Fast Track designation to ATR-04, demonstrating that the FDA. Salva continued, \"In addition to ATR-12, Azitra has made significant progress with our next most advanced product, ATR-04. ATR-04 is a live biotherapeutic product candidate containing an isolated, naturally derived S. epidermidis strain being developed for the treatment of EGFR inhibitor  associated rash, which impacts approxim","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","SID","AZTR","BK4006","LU1481600234.SGD","LU1487256676.USD","IP","LU1481599808.USD","BK4585","LU2463526074.USD","BK4136"],"gpt_icon":0},{"id":"2509956874","title":"Azitra Prices $930,000 Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2509956874","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509956874?lang=en_us&edition=fundamental","pubTime":"2025-02-05 03:48","pubTimestamp":1738698512,"startTime":"0","endTime":"0","summary":"Azitra  said Tuesday it has priced a registered direct offering of about 3.34 million common shares at $0.2785 per share to raise nearly $930,000 in gross proceeds.Azitra said it plans to use the net proceeds from the offering for working capital and general corporate purposes.The offering is set to close on Wednesday, pending customary closing conditions.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","AZTR"],"gpt_icon":0},{"id":"2509936254","title":"Azitra sees 3.34M shares at 27.85c in registered direct offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2509936254","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509936254?lang=en_us&edition=fundamental","pubTime":"2025-02-05 03:25","pubTimestamp":1738697123,"startTime":"0","endTime":"0","summary":"Azitra (AZTR) entered into a securities purchase agreement with institutional investors to purchase 3,339,300 shares of common stock at an offering...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/azitra-sees-3-34m-shares-at-27-85c-in-registered-direct-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/azitra-sees-3-34m-shares-at-27-85c-in-registered-direct-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AZTR"],"gpt_icon":0},{"id":"2509449337","title":"Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2509449337","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509449337?lang=en_us&edition=fundamental","pubTime":"2025-02-05 03:20","pubTimestamp":1738696813,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250204:nTUA4XHWFC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AZTR","BK4139"],"gpt_icon":0},{"id":"2509493770","title":"Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2509493770","media":"PR Newswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509493770?lang=en_us&edition=fundamental","pubTime":"2025-02-05 03:20","pubTimestamp":1738696800,"startTime":"0","endTime":"0","summary":"BRANFORD, Conn., Feb. 4, 2025 /PRNewswire/ --Azitra, Inc., a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that it has entered into a securities purchase agreement with certain institutional investor to purchase 3,339,300 shares of common stock at an offering price of $0.2785 per share, in a registered direct offering. The gross proceeds for the offering are expected to be approximately $930.0 thousand before deducting placement agent fees and other offering expenses. This offering is expected to close on February 5, 2025, subject to customary closing conditions. Azitra intends to use the net proceeds of this offering for working capital and general corporate purposes.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/azitra-announces-pricing-930-0-192000942.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/azitra-announces-pricing-930-0-192000942.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AZTR","BK4139"],"gpt_icon":0},{"id":"2508572214","title":"US Stocks Mixed; PepsiCo Posts Downbeat Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2508572214","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508572214?lang=en_us&edition=fundamental","pubTime":"2025-02-04 22:44","pubTimestamp":1738680249,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/02/43464430/us-stocks-mixed-pepsico-posts-downbeat-sales","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PEP","VLCN","OMGA","EJH","AZTR","QNTM","UPC"],"gpt_icon":0},{"id":"2508308149","title":"Azitra, Inc. to Present at the BIO CEO & Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2508308149","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508308149?lang=en_us&edition=fundamental","pubTime":"2025-02-03 22:05","pubTimestamp":1738591500,"startTime":"0","endTime":"0","summary":"During the conference, members ofAzitra's management team will conduct one-on-one meetings with registered investors and potential partners, showcasing the company's business and clinical development strategy, recent corporate achievements, and anticipated milestones.This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may be identified by words such as \"aims,\" \"anticipates,\" \"believes,\" \"could,\" \"estimates,\" \"expects,\" \"forecasts,\" \"goal,\" \"intends,\" \"may,\" \"plans,\" \"possible,\" \"potential,\" \"seeks,\" \"will,\" and variations of these words or similar expressions that are intended to identify forward-looking statements. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements include, without limitation, statements regarding the expected timing of the presentation of data from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/azitra-inc-present-bio-ceo-140500428.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/azitra-inc-present-bio-ceo-140500428.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BIO","BK4588","LU1169590202.USD","BK4585","AZTR","BK4139","LU1169589451.USD","BK4121"],"gpt_icon":0},{"id":"2506808605","title":"Azitra, Inc. to Present at The Microcap Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2506808605","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506808605?lang=en_us&edition=fundamental","pubTime":"2025-01-28 05:05","pubTimestamp":1738011900,"startTime":"0","endTime":"0","summary":"Borgata Hotel Casino & Spa, Studio C, Atlantic City, NJ. During the conference, members of Azitra's management team will conduct one-on-one meetings with registered investors and potential partners, showcasing the company's business and clinical development strategy, recent corporate achievements, and anticipated milestones.This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may be identified by words such as \"aims,\" \"anticipates,\" \"believes,\" \"could,\" \"estimates,\" \"expects,\" \"forecasts,\" \"goal,\" \"intends,\" \"may,\" \"plans,\" \"possible,\" \"potential,\" \"seeks,\" \"will,\" and variations of these words or similar expressions that are intended to identify forward-looking statements. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements include, without limitation, statements rega","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/azitra-inc-present-microcap-conference-210500846.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/azitra-inc-present-microcap-conference-210500846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","AZTR"],"gpt_icon":0},{"id":"2503677640","title":"Dow Jumps 600 Points; US Inflation Increases To 2.9% In December","url":"https://stock-news.laohu8.com/highlight/detail?id=2503677640","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503677640?lang=en_us&edition=fundamental","pubTime":"2025-01-15 22:54","pubTimestamp":1736952856,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"27e9d6568c45e173e7a4c03c411f8396","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/01/43004596/dow-jumps-600-points-us-inflation-increases-to-2-9-in-december","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZTR","BK4122","BK4129","USJW.SI","WNW","BK4139","QID","BK4167","SGBX","TSYW.SI","PCOM","SQQQ","QLD","NVIW.SI","USAW.SI","MNQmain","BK4113","MITQ","BK4190","ACON","PSQ",".IXIC","BK4539","BK4108","NQmain","TQQQ"],"gpt_icon":1},{"id":"2503646515","title":"Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2503646515","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503646515?lang=en_us&edition=fundamental","pubTime":"2025-01-15 21:30","pubTimestamp":1736947818,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250115:nFWN3OB0AW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AZTR"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZTR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-07-01","symbol":"AZTR","defaultRemindTime":1719840600000,"type":"split","dateTimestamp":1719806400000,"forFactor":30,"toFactor":1,"ratio":30}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZTR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZTR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1709265600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AZTR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AZTR","date":"2025-05-15","current":-0.457627,"percent":0.700441,"low":-5.58964,"twenty":-1.413562,"median":-0.549564,"eighty":-0.404503,"high":-0.185344,"avg":-1.045341,"sd":1.117923,"marketCap":4165758},"quantilePoints":[{"date":"2023-06-16","current":-5.58964,"twenty":-5.58964,"median":-5.58964,"eighty":-5.58964,"marketCap":60432550},{"date":"2023-06-23","current":-5.399592,"twenty":-5.535979,"median":-5.477847,"eighty":-5.319101,"marketCap":58377843},{"date":"2023-06-30","current":-4.158692,"twenty":-5.495734,"median":-4.997138,"eighty":-4.683,"marketCap":44961817},{"date":"2023-07-07","current":-4.102796,"twenty":-5.446545,"median":-4.779142,"eighty":-4.362155,"marketCap":44357491},{"date":"2023-07-14","current":-4.516429,"twenty":-5.23861,"median":-4.527608,"eighty":-4.362155,"marketCap":48829500},{"date":"2023-07-21","current":-4.471712,"twenty":-4.912176,"median":-4.545495,"eighty":-4.476184,"marketCap":48346040},{"date":"2023-07-28","current":-4.046899,"twenty":-4.782496,"median":-4.527608,"eighty":-4.268249,"marketCap":43753166},{"date":"2023-08-04","current":-2.683027,"twenty":-4.767963,"median":-4.499884,"eighty":-4.151985,"marketCap":29007624},{"date":"2023-08-11","current":-3.040764,"twenty":-4.731474,"median":-4.477302,"eighty":-4.060314,"marketCap":32875307},{"date":"2023-08-18","current":-2.775015,"twenty":-4.690311,"median":-4.281664,"eighty":-3.058651,"marketCap":30002154},{"date":"2023-08-25","current":-1.902871,"twenty":-4.641637,"median":-4.231357,"eighty":-2.884254,"marketCap":25405050},{"date":"2023-09-01","current":-1.803197,"twenty":-4.5827,"median":-4.147513,"eighty":-2.714329,"marketCap":24074309},{"date":"2023-09-08","current":-1.902871,"twenty":-4.560878,"median":-4.102796,"eighty":-2.060538,"marketCap":25405050},{"date":"2023-09-15","current":-1.585817,"twenty":-4.544154,"median":-3.834493,"eighty":-1.953615,"marketCap":21172085},{"date":"2023-09-21","current":-1.61291,"twenty":-4.538788,"median":-3.091071,"eighty":-1.911933,"marketCap":21533804},{"date":"2023-09-29","current":-1.449807,"twenty":-4.516429,"median":-3.018406,"eighty":-1.812258,"marketCap":19356228},{"date":"2023-10-06","current":-1.359194,"twenty":-4.516429,"median":-2.884254,"eighty":-1.757891,"marketCap":18146464},{"date":"2023-10-13","current":-1.223274,"twenty":-4.499884,"median":-2.775015,"eighty":-1.61291,"marketCap":16331818},{"date":"2023-10-20","current":-1.631033,"twenty":-4.482891,"median":-2.442461,"eighty":-1.531358,"marketCap":21775757},{"date":"2023-10-27","current":-1.495113,"twenty":-4.482891,"median":-2.138465,"eighty":-1.509611,"marketCap":19961110},{"date":"2023-11-03","current":-1.40441,"twenty":-4.478419,"median":-1.984423,"eighty":-1.435308,"marketCap":18750136},{"date":"2023-11-10","current":-1.694462,"twenty":-4.458297,"median":-1.96177,"eighty":-1.420811,"marketCap":22622592},{"date":"2023-11-17","current":-1.465632,"twenty":-4.37557,"median":-1.920994,"eighty":-1.431684,"marketCap":18872323},{"date":"2023-11-24","current":-1.211965,"twenty":-4.277192,"median":-1.902871,"eighty":-1.413562,"marketCap":15605959},{"date":"2023-12-01","current":-0.977088,"twenty":-4.25707,"median":-1.832646,"eighty":-1.395439,"marketCap":12581548},{"date":"2023-12-08","current":-0.920718,"twenty":-4.241419,"median":-1.803197,"eighty":-1.359194,"marketCap":11855690},{"date":"2023-12-15","current":-1.343496,"twenty":-4.20341,"median":-1.74883,"eighty":-1.354152,"marketCap":17299629},{"date":"2023-12-22","current":-1.207362,"twenty":-4.156456,"median":-1.638553,"eighty":-1.313887,"marketCap":15546681},{"date":"2023-12-29","current":-0.995972,"twenty":-4.149749,"median":-1.634793,"eighty":-1.283368,"marketCap":12824711},{"date":"2024-01-05","current":-0.995878,"twenty":-4.143041,"median":-1.631033,"eighty":-1.233783,"marketCap":12823501},{"date":"2024-01-12","current":-0.972391,"twenty":-4.122919,"median":-1.585771,"eighty":-1.215761,"marketCap":12521060},{"date":"2024-01-19","current":-1.925991,"twenty":-4.098324,"median":-1.585771,"eighty":-1.213863,"marketCap":24800168},{"date":"2024-01-26","current":-1.249546,"twenty":-4.073729,"median":-1.531358,"eighty":-1.221818,"marketCap":16089865},{"date":"2024-02-02","current":-1.089829,"twenty":-3.961937,"median":-1.519884,"eighty":-1.211965,"marketCap":14033265},{"date":"2024-02-09","current":-0.967693,"twenty":-3.517002,"median":-1.493818,"eighty":-1.195054,"marketCap":12460572},{"date":"2024-02-16","current":-0.833723,"twenty":-3.094425,"median":-1.466781,"eighty":-1.167586,"marketCap":10735497},{"date":"2024-02-23","current":-0.571872,"twenty":-3.085481,"median":-1.465632,"eighty":-1.12741,"marketCap":7363748},{"date":"2024-03-01","current":-0.569638,"twenty":-3.040764,"median":-1.449807,"eighty":-1.080434,"marketCap":7334983},{"date":"2024-03-08","current":-0.5091,"twenty":-3.018406,"median":-1.436214,"eighty":-1.024064,"marketCap":6555462},{"date":"2024-03-15","current":-0.533896,"twenty":-2.973688,"median":-1.413562,"eighty":-0.986483,"marketCap":6874749},{"date":"2024-03-22","current":-0.577176,"twenty":-2.884254,"median":-1.406836,"eighty":-0.977088,"marketCap":6512729},{"date":"2024-03-28","current":-0.512081,"twenty":-2.884254,"median":-1.395439,"eighty":-0.95454,"marketCap":5778211},{"date":"2024-04-05","current":-0.602448,"twenty":-2.82165,"median":-1.381077,"eighty":-0.91696,"marketCap":6797895},{"date":"2024-04-12","current":-0.465876,"twenty":-2.781212,"median":-1.359194,"eighty":-0.858373,"marketCap":5256847},{"date":"2024-04-19","current":-0.484509,"twenty":-2.764029,"median":-1.359194,"eighty":-0.602141,"marketCap":5467092},{"date":"2024-04-26","current":-0.56186,"twenty":-2.698678,"median":-1.348194,"eighty":-0.592185,"marketCap":6339901},{"date":"2024-05-03","current":-0.561349,"twenty":-2.298121,"median":-1.33201,"eighty":-0.590246,"marketCap":6334140},{"date":"2024-05-10","current":-0.634358,"twenty":-2.100408,"median":-1.309357,"eighty":-0.590246,"marketCap":7157953},{"date":"2024-05-17","current":-0.485733,"twenty":-2.060538,"median":-1.287126,"eighty":-0.577789,"marketCap":5711960},{"date":"2024-05-24","current":-0.495041,"twenty":-1.998921,"median":-1.258941,"eighty":-0.571425,"marketCap":5821418},{"date":"2024-05-31","current":-0.477649,"twenty":-1.978986,"median":-1.23641,"eighty":-0.56671,"marketCap":5616905},{"date":"2024-06-07","current":-0.40441,"twenty":-1.975362,"median":-1.223274,"eighty":-0.560644,"marketCap":4755646},{"date":"2024-06-14","current":-0.355665,"twenty":-1.964488,"median":-1.211965,"eighty":-0.547207,"marketCap":4182434},{"date":"2024-06-21","current":-0.348806,"twenty":-1.948178,"median":-1.211965,"eighty":-0.531751,"marketCap":4101781},{"date":"2024-06-28","current":-0.323332,"twenty":-1.948178,"median":-1.207362,"eighty":-0.527437,"marketCap":3802212},{"date":"2024-07-05","current":-0.191876,"twenty":-1.946474,"median":-1.193175,"eighty":-0.519324,"marketCap":2256361},{"date":"2024-07-12","current":-0.262095,"twenty":-1.936747,"median":-1.171479,"eighty":-0.513791,"marketCap":3082094},{"date":"2024-07-15","current":-0.249847,"twenty":-1.933161,"median":-1.16499,"eighty":-0.513107,"marketCap":2938071},{"date":"2024-08-02","current":-0.505188,"twenty":-1.929576,"median":-1.160292,"eighty":-0.511877,"marketCap":5940751},{"date":"2024-08-09","current":-0.326677,"twenty":-1.921993,"median":-1.12741,"eighty":-0.508698,"marketCap":3841548},{"date":"2024-08-16","current":-0.508927,"twenty":-1.913745,"median":-1.094479,"eighty":-0.508559,"marketCap":5069899},{"date":"2024-08-23","current":-0.572533,"twenty":-1.904683,"median":-1.080434,"eighty":-0.504719,"marketCap":5703541},{"date":"2024-08-30","current":-0.491781,"twenty":-1.902871,"median":-1.028761,"eighty":-0.504719,"marketCap":4899098},{"date":"2024-09-06","current":-0.446316,"twenty":-1.872969,"median":-0.995925,"eighty":-0.498634,"marketCap":4446170},{"date":"2024-09-13","current":-0.447771,"twenty":-1.828568,"median":-0.986483,"eighty":-0.492929,"marketCap":4460665},{"date":"2024-09-20","current":-0.458486,"twenty":-1.806821,"median":-0.986483,"eighty":-0.488525,"marketCap":4567408},{"date":"2024-09-27","current":-0.425726,"twenty":-1.803197,"median":-0.972391,"eighty":-0.483591,"marketCap":4241056},{"date":"2024-10-04","current":-0.382709,"twenty":-1.797955,"median":-0.948903,"eighty":-0.474913,"marketCap":3812528},{"date":"2024-10-11","current":-0.380413,"twenty":-1.788828,"median":-0.939508,"eighty":-0.460002,"marketCap":3789652},{"date":"2024-10-18","current":-0.447829,"twenty":-1.768764,"median":-0.901928,"eighty":-0.454812,"marketCap":4461242},{"date":"2024-10-25","current":-0.421035,"twenty":-1.747017,"median":-0.864535,"eighty":-0.451467,"marketCap":4194330},{"date":"2024-10-31","current":-0.390568,"twenty":-1.721646,"median":-0.679541,"eighty":-0.447115,"marketCap":3890813},{"date":"2024-11-08","current":-0.387353,"twenty":-1.672098,"median":-0.649036,"eighty":-0.440762,"marketCap":3858784},{"date":"2024-11-15","current":-0.381043,"twenty":-1.638553,"median":-0.603725,"eighty":-0.431797,"marketCap":3440113},{"date":"2024-11-22","current":-0.397008,"twenty":-1.635545,"median":-0.600404,"eighty":-0.42943,"marketCap":3584246},{"date":"2024-11-29","current":-0.443466,"twenty":-1.631033,"median":-0.593224,"eighty":-0.428634,"marketCap":4003679},{"date":"2024-12-06","current":-0.406469,"twenty":-1.627408,"median":-0.591753,"eighty":-0.425604,"marketCap":3669658},{"date":"2024-12-13","current":-0.397684,"twenty":-1.607491,"median":-0.589174,"eighty":-0.420859,"marketCap":3590347},{"date":"2024-12-20","current":-0.333825,"twenty":-1.585799,"median":-0.580807,"eighty":-0.418884,"marketCap":3013817},{"date":"2024-12-27","current":-0.344383,"twenty":-1.585726,"median":-0.577176,"eighty":-0.415622,"marketCap":3109143},{"date":"2025-01-03","current":-0.375722,"twenty":-1.584421,"median":-0.573602,"eighty":-0.411894,"marketCap":3392069},{"date":"2025-01-10","current":-0.331628,"twenty":-1.552453,"median":-0.572533,"eighty":-0.405083,"marketCap":2993989},{"date":"2025-01-17","current":-0.227224,"twenty":-1.531358,"median":-0.570755,"eighty":-0.401631,"marketCap":2051409},{"date":"2025-01-24","current":-0.212948,"twenty":-1.527616,"median":-0.567057,"eighty":-0.398783,"marketCap":1922528},{"date":"2025-01-31","current":-0.213033,"twenty":-1.520308,"median":-0.56186,"eighty":-0.398223,"marketCap":1923291},{"date":"2025-02-07","current":-0.326307,"twenty":-1.508705,"median":-0.560468,"eighty":-0.394676,"marketCap":2945945},{"date":"2025-02-14","current":-0.697553,"twenty":-1.494595,"median":-0.56186,"eighty":-0.397008,"marketCap":6297608},{"date":"2025-02-21","current":-0.716832,"twenty":-1.48864,"median":-0.56671,"eighty":-0.397143,"marketCap":6471662},{"date":"2025-02-28","current":-0.586313,"twenty":-1.46747,"median":-0.568521,"eighty":-0.397761,"marketCap":5257753},{"date":"2025-03-07","current":-0.551234,"twenty":-1.465633,"median":-0.567404,"eighty":-0.398147,"marketCap":4943186},{"date":"2025-03-14","current":-0.579297,"twenty":-1.465632,"median":-0.571576,"eighty":-0.398458,"marketCap":5194839},{"date":"2025-03-21","current":-0.547893,"twenty":-1.462467,"median":-0.571872,"eighty":-0.398521,"marketCap":4913228},{"date":"2025-03-28","current":-0.546223,"twenty":-1.449807,"median":-0.568521,"eighty":-0.398697,"marketCap":4898248},{"date":"2025-04-04","current":-0.490264,"twenty":-1.449214,"median":-0.56671,"eighty":-0.39874,"marketCap":4396440},{"date":"2025-04-11","current":-0.467714,"twenty":-1.445623,"median":-0.562229,"eighty":-0.39905,"marketCap":4194219},{"date":"2025-04-17","current":-0.531189,"twenty":-1.440745,"median":-0.561476,"eighty":-0.399601,"marketCap":4763434},{"date":"2025-04-25","current":-0.511144,"twenty":-1.431684,"median":-0.559586,"eighty":-0.401232,"marketCap":4583682},{"date":"2025-05-02","current":-0.547893,"twenty":-1.431684,"median":-0.554496,"eighty":-0.401897,"marketCap":4913228},{"date":"2025-05-09","current":-0.497614,"twenty":-1.413562,"median":-0.551234,"eighty":-0.40441,"marketCap":4462349},{"date":"2025-05-15","current":-0.457627,"twenty":-1.413562,"median":-0.549564,"eighty":-0.404503,"marketCap":4165758}],"updateTime":1747450791325}}}